SCHEMBL17875922

SCHEMBL17875922

O=S1(=O)Cc2cc(-n3c4ccccc4c4ccccc43)ccc2-c2cc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)ccc2C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HDAC4 P56524 1/20 0.34
TYRO3 Q06418 1/20 0.33
NTRK2 Q16620 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
TDP2 O95551 1/20 0.33
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
APAF1 O14727 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
XBP1 P17861 1/20 0.31
PTBP1 P26599 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875954 0.95 TDP2 (0.35) ATML3MBTL1KDM4EHDAC4TYRO3
SCHEMBL17875984 0.94 L3MBTL1 (0.37) ATML3MBTL1KDM4EHDAC4TYRO3
SCHEMBL17875913 0.91 KDM4E (0.36) ATML3MBTL1KDM4EEDNRBEDNRA
SCHEMBL17875925 0.89 CYP11B1 (0.38) CLK4TDP2MEN1KMT2ALMNA
SCHEMBL17875972 0.86 KDM4E (0.36) ATML3MBTL1KDM4ETDP2EDNRB
SCHEMBL17876016 0.85 MEN1 (0.34) ATML3MBTL1KDM4EHDAC4MEN1
SCHEMBL17877790 0.85 PTGDR2 (0.33)
SCHEMBL17875986 0.84 KDM4E (0.38) ATML3MBTL1KDM4EEDNRBEDNRA
SCHEMBL17875963 0.84 CYP11B1 (0.41) CLK4TDP2MEN1KMT2ALMNA
SCHEMBL17875919 0.84 SMN1; SMN2 (0.33) KDM4EEDNRBEDNRAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 ATM 1164/4885L3MBTL1 768/4885KDM4E 3120/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ATM 1164/4885L3MBTL1 768/4885KDM4E 3120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.